ERIC 2018 | Projections from real world evidence of CLL management
Robin Foà
• 25 Oct 2018
Although major developments are being made in the treatment of chronic lymphocytic leukemia (CLL), in many settings in the real world these novel therapies are not available. Here, Robin Foà, MD, of the Sapienza University of Rome, Rome, Italy, discusses projections from real world evidence on the landscape of CLL management, including the cost of drugs, differing healthcare systems in between countries, the age and life expectancy of patients, and more. This interview took place at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.
